Summary
Dennis Simpson is a Senior Scientist and research leader with 11+ years driving cell biology, DNA repair, and molecular biology programs at UNC Chapel Hill, where he mentors teams and oversees complex, high-risk projects. He has authored 30+ publications and holds five patents licensed to Alphavax, translating deep mechanistic insight into tangible biomedical outcomes. His recent work elucidates Mre11 signaling and Polymerase Theta (PolQ) roles in cell-cycle–dependent DNA repair and tumor dependency, guiding target discovery and small-molecule inhibitor studies. Comfortable spanning bench to bioinformatics, he has built end-to-end pipelines from cell assays to computational analysis and managed multi-hundred-thousand-dollar research budgets. Colleagues rely on him for experimental design, regulatory compliance, and turning exploratory science into clinically relevant programs.
11 years of coding experience
15 years of employment as a software developer
B.S., Microbiology and Public Health, B.S., Microbiology and Public Health at Michigan State University
PhD, Virology, PhD, Virology at University of North Carolina at Chapel Hill